Misinformation and Facts about Breast Cancer Screening

Quality medical practice is based on science and evidence. For over a half-century, the efficacy of breast cancer screening has been challenged, particularly for women aged 40–49. As each false claim has been raised, it has been addressed and refuted based on science and evidence. Nevertheless, misi...

Full description

Bibliographic Details
Main Author: Daniel B. Kopans
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/29/8/445
_version_ 1797410723988504576
author Daniel B. Kopans
author_facet Daniel B. Kopans
author_sort Daniel B. Kopans
collection DOAJ
description Quality medical practice is based on science and evidence. For over a half-century, the efficacy of breast cancer screening has been challenged, particularly for women aged 40–49. As each false claim has been raised, it has been addressed and refuted based on science and evidence. Nevertheless, misinformation continues to be promoted, resulting in confusion for women and their physicians. Early detection has been proven to save lives for women aged 40–74 in randomized controlled trials of mammography screening. Observational studies, failure analyses, and incidence of death studies have provided evidence that there is a major benefit when screening is introduced to the general population. In large part due to screening, there has been an over 40% decline in deaths from breast cancer since 1990. Nevertheless, misinformation about screening continues to be promoted, adding to the confusion. Despite claims to the contrary, a careful reading of the guidelines issued by major groups such as the U.S. Preventive Services Task Force and the American College of Physicians shows that they all agree that most lives are saved by screening starting at the age of 40. There is no scientific support for using the age of 50 as a threshold for screening. All women should be provided with the facts and not false information about breast cancer screening so that they can make “informed decisions” for themselves about whether to participate.
first_indexed 2024-03-09T04:33:57Z
format Article
id doaj.art-6bbeeb6c7544495c90a00faf1de7b576
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-09T04:33:57Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-6bbeeb6c7544495c90a00faf1de7b5762023-12-03T13:30:48ZengMDPI AGCurrent Oncology1198-00521718-77292022-08-012985644565410.3390/curroncol29080445Misinformation and Facts about Breast Cancer ScreeningDaniel B. Kopans0Harvard Medical School, Boston, MA 02114, USAQuality medical practice is based on science and evidence. For over a half-century, the efficacy of breast cancer screening has been challenged, particularly for women aged 40–49. As each false claim has been raised, it has been addressed and refuted based on science and evidence. Nevertheless, misinformation continues to be promoted, resulting in confusion for women and their physicians. Early detection has been proven to save lives for women aged 40–74 in randomized controlled trials of mammography screening. Observational studies, failure analyses, and incidence of death studies have provided evidence that there is a major benefit when screening is introduced to the general population. In large part due to screening, there has been an over 40% decline in deaths from breast cancer since 1990. Nevertheless, misinformation about screening continues to be promoted, adding to the confusion. Despite claims to the contrary, a careful reading of the guidelines issued by major groups such as the U.S. Preventive Services Task Force and the American College of Physicians shows that they all agree that most lives are saved by screening starting at the age of 40. There is no scientific support for using the age of 50 as a threshold for screening. All women should be provided with the facts and not false information about breast cancer screening so that they can make “informed decisions” for themselves about whether to participate.https://www.mdpi.com/1718-7729/29/8/445breastcancerscreening
spellingShingle Daniel B. Kopans
Misinformation and Facts about Breast Cancer Screening
Current Oncology
breast
cancer
screening
title Misinformation and Facts about Breast Cancer Screening
title_full Misinformation and Facts about Breast Cancer Screening
title_fullStr Misinformation and Facts about Breast Cancer Screening
title_full_unstemmed Misinformation and Facts about Breast Cancer Screening
title_short Misinformation and Facts about Breast Cancer Screening
title_sort misinformation and facts about breast cancer screening
topic breast
cancer
screening
url https://www.mdpi.com/1718-7729/29/8/445
work_keys_str_mv AT danielbkopans misinformationandfactsaboutbreastcancerscreening